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a  b  s  t  r  a  c  t
A  patient  who  had  a primary  undifferentiated  high-grade  pleomorphic  sarcoma/malignant  ﬁbrous  histio-
cytoma  that  apparently  arose  in the  mandible,  but  showed  uncertain  differentiation  on  histopathological
examination,  is described.  Our  regimen,  a combination  of  pre-  and  postoperative  chemotherapy  andccepted 15 January 2014
eywords:
ndifferentiated high-grade pleomorphic
arcoma/malignant ﬁbrous histiocytoma
AC therapy
surgical  resection,  produced  a good  outcome.
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. Introduction
Sarcomas arising in the oral region have a much lower incidence
han epithelial tumors, accounting for 1.8% of all primary malig-
ant oral tumors surveyed in Japan [1]. Undifferentiated sarcoma
ccounts for only 0.1% of sarcomas in the oral cavity [1]. Histopatho-
ogically, this tumor shows diverse features; standard treatment
as not yet been established. In this article, a patient who had
n undifferentiated high-grade pleomorphic sarcoma/malignant
brous histiocytoma that apparently arose in the mandible, but
howed no speciﬁc line of differentiation on histopathological
xamination, is described.
.  Case report
An 8-year-old boy was admitted to our hospital because of pain
nd bleeding of the right mandibular deciduous molar region and
welling of the right buccal region. His medical and family histories
ere not relevant to the current disorder. Facial ﬁndings revealed
n elastic hard mass in the right buccal region (Fig. 1A). There were
o abnormalities of the facial skin, but trismus was  present. An
xophytic region with gingival hyperplasia at the region was  found
Fig. 1B).
∗ Corresponding author. Tel.: +81 3 5800 8669; fax: +81 3 5800 6832.
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ttp://dx.doi.org/10.1016/S1348-8643(14)00002-0Computerized tomography (CT) scans revealed osteolytic
changes and a mass measuring about 4 cm in diameter in the right
side of the mandible. The inside of the lesion showed a relatively
low, heterogeneous density (Fig. 2A and B). Radiographic ﬁndings
suggested osteomyelitis, but that was  considered unlikely because
of mild inﬂammation. The clinical diagnosis was a suspected tumor
in the right mandible.
A  few days later, a biopsy was performed under general anes-
thesia to make a deﬁnite diagnosis. Histologically, the tumor
was markedly cellular with the proliferation of spindle tumor
cells arranged in fascicular and storiform patterns, intermin-
gled with occasional giant cells with bizarre nuclei (Fig. 3A–C).
Mitotic ﬁgures were commonly seen within the tumor (approxi-
mately 10/high-power ﬁelds (HPFs)), along with the focal areas of
necrosis and hemorrhage. The tumor showed no speciﬁc line of
differentiation including matrix production, such as bone and car-
tilage. Furthermore, immunohistochemical examination showed
no speciﬁc differentiation (Table 1). However, the diagnosis of
synovial sarcoma was ruled out by the facts that the tumor was
essentially a bone tumor on the imaging survey and that the
fusion genes (SYT-SSX1 and SYT-SSX2), which are cytogeneti-
cally speciﬁc markers for synovial sarcoma, were not detected
by reverse transcription polymerase chain reaction (RT-PCR) on
tumor samples (data not shown). Although the deﬁnite pathologi-
cal diagnosis was  unable using limited biopsy specimen, the tumor
fell under the category of undifferentiated high-grade pleomor-
phic sarcoma/malignant ﬁbrous histiocytoma of indeterminable
evier Ltd. All rights reserved.
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Fig. 2. Axial (A) and 3-dimensional (B) CT images. Osteolytic changes and a mass
measuring about 4 cm in diameter are found in the right side of the mandibleig. 1. Facial and oral ﬁndings at the initial visit. The patient’s cheek is swollen, and
ral examination shows an exophytic region with gingival hyperplasia at the distal
ingiva of the right mandibular deciduous molar region.
ifferentiation based on the histopathological and molecular
athological ﬁndings.
The  patient was transferred to the Department of Pediatrics
f our hospital to undergo chemotherapy. He was given ifos-
amide plus etoposide (IE therapy), followed by one course of
hemotherapy with vincristine, actinomycin D and cyclophos-
hamide (VAC therapy) (Fig. 4). A month after the therapy, the
ass associated with destruction of the right side of the mandible
ad markedly shrunk to about 2.5 cm × 2.2 cm on CT scans. There
as no enlargement of the cervical lymph nodes on either side.
he patient subsequently received three courses of VAC therapy,
or a total of four courses of VAC therapy. The CT scans showed
hat the tumor had decreased. Since there was no evidence of dis-
ant metastasis to the chest or abdomen, the tumor was  resected
y right mandibular segmentectomy under general anesthesia 1
onth after chemotherapy. The resected mandible was  recon-
tructed with a vascularized rectus abdominis musculocutaneous
ap. During the operation, intermaxillary ﬁxation was placed on
he deciduous molars of the unaffected side using a multi-bracket
ppliance and bite splint fabricated before surgery. After surgery,
he contour of the face and the occlusion were favorably main-
ained. The occlusion was retained by intermaxillary ﬁxation for 3(arrows).
days after surgery. A functional appliance (bionator) was applied
for 7 months after surgery.
The  resected specimen, measuring 6.5 cm × 5.0 cm × 3.2 cm,
included the right mandibular bone and the surrounding mus-
cle tissue. The second deciduous molar and the ﬁrst molar, as
well as the surrounding oral mucosa, were also included in the
specimen. On the cut surface, an ill-demarcated soft mass, measur-
ing 2.5 cm × 1.5 cm × 1.0 cm in size, was  located in the mandible,
with the destruction of cortical bone and extending directly to the
submucosa (Fig. 5A). Histologically, the tumor cells had almost dis-
appeared and were replaced by ﬁbrosis. The residual tumor cells
were seen scattered at the periphery of ﬁbrosis, with backgrounds
of edema and hemorrhage, which underwent marked degenerative
change with hyperchromatic, irregularly shaped nuclei (Fig. 5B and
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Fig. 3. Histopathological examination: low power (A), (B) and high power view (C). (A) The tumor was highly cellular with focal necrosis and hemorrhage. (B) The tumor is
cellular  with proliferation of spindle-shaped cells with pleomorphism (20×, hematoxylin and eosin stain (HE)). (C) At high power, spindle-shaped cells with atypical nuclei
are  intermingled with occasional giant cells with bizarre nuclei (arrow head). Mitotic ﬁgures (arrows) are frequently seen with focal atypical mitosis (white arrow) (40×,
HE).
Fig. 4. The timeline of chemotherapy (each scale mark is 1 month).
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Fig. 5. (A) The resected specimen of the mandibular tumor measuring 6.5 cm × 5.0 cm × 3.2 cm includes the right mandibular bone and the surrounding muscle tissue. On
the  cut surface of the resected specimen, an intraosseous tumor of the mandibular bone 
The  tumor is replaced by ﬁbrosis with destruction of the mandibular bone with involvem
degenerative tumor cells with atypical nuclei (arrows) observed rescattered with hemorr
Table 1
Immunohistochemical examinations of the tissue obtained at biopsy.
Immunohistochemical examination Findings
Cytokeratin (AE/AE3) (−)
Cytokeratin (CAM5.2) Focal+
Epithelial membrane antigen (−)
Vimentin Focal+
Desmin (−)
Myoglobin (−)
Muscle-speciﬁc action (HHF35) (+)
Smooth muscle actin (1A4) (−)
Caldesmon (−)
Calponin (−)
S100 protein (−)
GFAP (−)
NSE (−)
CD99 (−)
CD56 Weak+
c-Kit (−)
HMB45 (−)
BCL-2 (+)
CD45(LCA) (−)
CD3 (−)
CD20 (−)
CD34 (−)
CD31 (−)
Factor VIII-related antigen (−)
D2-40 (−)shows a ﬁbrous appearance with an expansile and destructive growth pattern. (B)
ent of the inferior alveolar nerve (arrow) (2×, HE). (C) At the periphery of ﬁbrosis,
hagic and edematous backgrounds (20×, HE).
C). The surgical cut-end of the specimen was negative for tumor
cells.
A month after surgical resection, VAC therapy was resumed. For
6 months after surgery, a total of 10 courses of chemotherapy were
delivered and the treatment was  completed (Fig. 4). At 7 years and 8
months after surgery, CT scans revealed no signs of local recurrence
and the patient showed no evidence of distant metastases to the
cervical lymph nodes or lung. His maxilla–mandibular relationship
was favorable, and the occlusion of the remaining teeth had been
maintained using the oral functional appliance (Fig. 6).
3.  Discussion
Primary high-grade sarcoma rarely arises in the mandibular
bone of children. The histological appearance of the tumor was
spindle cell like and the pleomorphic morphology was  without any
speciﬁc line of differentiation, which causes difﬁculty in making
pathological diagnosis. In general, histological typing of high-grade
sarcomas is often problematic on a biopsy specimen due to intra-
tumoral heterogeneity and undeterminable differentiation status
that is often observed in sarcomas. In such instances, the ﬁnal
pathological diagnosis should be made through extensive histolog-
ical and immunohistochemical examination of surgical specimens.
In the present surgical specimen, no additional useful information
for pathological diagnosis was  obtained, because most of the tumor
cells had disappeared by effective preoperative chemotherapy.
According to the World Health Organization (WHO) classi-
ﬁcation of tumor of bone (2013) [3], differential diagnosis of
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Fig. 6. CT image, facial and oral photographs at 7 years and 8 months after surgery. (A) Signs of local recurrence and obvious deformity of the mandible are not seen on the
three-dimensional (3D)-CT image. (B) No distinct deformity of the face is found. (C) The reconstructed region in the mandible using a rectus abdominis musculocutaneous
ﬂ
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tap (arrow). (D) The occlusion has been kept stable.
he present tumor includes spindle-shaped cell and pleomorphic
arcomas such as osteosarcoma (both osteoblastic and ﬁbro-
lastic subtypes), leiomyosarcoma, undifferentiated high-grade
leomorphic sarcoma, undifferentiated high-grade pleomorphic
arcoma/malignant ﬁbrous histiocytoma and malignant peripheral
erve sheath tumor (MPNST). Although rare, synovial sarcoma, a
oft-tissue tumor that shows epithelial differentiation, has been
eported as a primary arising from the bone [2]. In this case,
onophasic synovial sarcoma was also added to the differential
iagnosis because the spindle-shaped cells of the tumor showed
eak positivity for both vimentin and cytokeratin. However, it
as excluded by negativity for tumor-speciﬁc fusion gene SYT-SSX
y using RT-PCR. Notably, aberrant expression of the cytokeratin
as sometimes observed in sarcomas, which is unrelated to true
pithelial differentiation [4]. Immunohistochemically, the tumor
howed positivity for HHF35, one of the muscle markers; however,
eiomyosarcoma was also excluded by negativity for other smooth
uscle markers. Coexpression of vimentin and HHF35 may  sug-
est potential myoﬁbroblastic differentiation, which is occasionally
een in osteosarcoma and undifferentiated pleomorphic sarcoma.
lthough tumors of the ﬁbrogenic group often show myoﬁbroblas-
ic phenotype, no possible high-grade sarcoma was  listed in theclassiﬁcation.  MPNST is diagnostically a problematic tumor that
often lacks expression of neurogenic markers. However, it is almost
unlikely by absence of symptoms suggesting neuroﬁbromatosis 1.
Finally, osteosarcoma may  also be ruled out, because no evidence of
neoplastic bone formation was noted despite pretherapeutic imag-
ing analyses and extensive histological examination of the surgical
specimen. In conclusion, the present tumor is exclusively classiﬁed
as undifferentiated high-grade pleomorphic sarcoma arising from
the mandible.
A  standard chemotherapy for sarcoma has not been established
in childhood except for osteosarcoma, Ewing sarcoma and rhab-
domyosarcoma because of the small number of cases. However, the
Intergroup Rhabdomyosarcoma Study (IRS) Group reported that
VAC therapy was effective for not only rhabdomyosarcoma but also
undifferentiated sarcoma [5].
In this case, the patient was given one course of IE therapy, which
is effective for sarcoma, while conﬁrmation of the pathological
diagnosis was  awaited. As the ﬁnal diagnosis, this tumor was likely a
high-grade undifferentiated sarcoma derived from the jaw in child-
hood, which cannot be classiﬁed into any categories. Consequently,
VAC therapy was  chosen as an induction chemotherapy. We  sus-
pected that the VAC therapy was  likely to be effective for this tumor
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hose biological nature was similar to Ewing’s sarcoma, showing
arked cellular growth with frequent mitotic ﬁgures within the
umor.
The IRS in the United States reported a disease-staging classiﬁca-
ion based on tumor site, histologic type and pre- and postoperative
ndings. Treatment has been evaluated to produce the best out-
omes and is now considered standard [6–9]. Thus, this case was
reated according to ‘Group 3’ in the IRS Postsurgical Grouping
lassiﬁcation [8]. The treatment protocol requires postoperative
adiotherapy. This patient did not receive radiotherapy for four rea-
ons: (1) the tumor was  completely resected by surgery, with no
vidence of metastasis to regional lymph nodes; (2) the patient
esponded well to preoperative chemotherapy; (3) there was  a risk
f development of a secondary cancer; and (4) a disturbance of jaw
rowth could occur. Late complications occur in 77% of patients
ith IRS II and III tumors of the head and neck (excluding orbital
esions) [10,11].
Recently, microsurgery is being performed more frequently in
hildren. Nakatsuka et al. reported that the safety and reliability
f microsurgery have been established in children [12]. The ﬁbula-
ree ﬂap technique for reconstruction of the mandible has been
eported to have advantages such as providing adequate length,
eliable shape, low donor morbidity and a distant location from
he mandible to facilitate a multi-team approach. However, hard-
issue reconstruction of the mandible was not performed this time,
nd a rectus abdominis musculocutaneous ﬂap was used for rein-
orcement of the defect after the mandibular segmentectomy. The
easons why hard-tissue reconstruction was not performed is that
here is no evidence to demonstrate that growth will occur in a
econstructed mandible using the ﬁbula bone as reported by Bidra
t al. [13]. Furthermore, we think that the vertical defect in the
econstructed mandible and the long waiting time before start-
ng dental implant placement and functional bone stimulation are
ajor problems in such a young patient [14]. Actually, we think that
he space occupied by the mandibular segmentectomy has been
aintained by the soft tissue of the rectus abdominis musculocu-aneous ﬂap, and the deviation of the mandible on the unaffected
ide has been minimized using a functional appliance. In future,
e are considering the use of the ﬁbula to repair bone defects in
dolescence.
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